Table 5 Features of transesophageal echocardiography between the two groups in TA patients with valve involvement
Parameters | ASO positive n = 10 | ASO negative n = 40 | P-Value |
|---|---|---|---|
Valvular prolapse, n(%) | 1 (10.0) | 3 (7.5) | 0.794 |
Valvular thickening, n(%) | 5 (50.0) | 4 (10.0) | 0.003 |
Valvular contracture, n(%) | 0 (0.0) | 1 (2.5) | – |
Left ventricular end-diastolic dimension, (mm) | 52.7 ± 12.5 | 47.7 ± 5.9 | 0.059 |
Ejection fraction, (%) | 54.7 ± 13.8 | 62.4 ± 9.2 | 0.042 |
Left atrium enlargement, n(%) | 3 (30.0) | 14 (35.0) | 0.765 |
Left ventricular diastolic dysfunction, n(%) | 2 (20.0) | 19 (47.5) | 0.115 |
Pulmonary hypertension, n(%) | 3 (30.0) | 3 (7.5) | 0.050 |